MidWestOne Financial Group Inc. Sells 94 Shares of Danaher Co. (NYSE:DHR)

MidWestOne Financial Group Inc. trimmed its position in shares of Danaher Co. (NYSE:DHR) by 2.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,868 shares of the conglomerate’s stock after selling 94 shares during the quarter. MidWestOne Financial Group Inc.’s holdings in Danaher were worth $1,075,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Prestige Wealth Management Group LLC increased its holdings in Danaher by 22.0% during the 3rd quarter. Prestige Wealth Management Group LLC now owns 1,528 shares of the conglomerate’s stock worth $425,000 after purchasing an additional 276 shares in the last quarter. Adalta Capital Management LLC increased its holdings in Danaher by 52.3% during the 3rd quarter. Adalta Capital Management LLC now owns 8,467 shares of the conglomerate’s stock worth $2,356,000 after purchasing an additional 2,907 shares in the last quarter. LRI Investments LLC increased its holdings in Danaher by 82.5% during the 3rd quarter. LRI Investments LLC now owns 4,545 shares of the conglomerate’s stock worth $1,264,000 after purchasing an additional 2,055 shares in the last quarter. Gordian Capital Singapore Pte Ltd increased its holdings in Danaher by 26.1% during the 3rd quarter. Gordian Capital Singapore Pte Ltd now owns 1,400 shares of the conglomerate’s stock worth $389,000 after purchasing an additional 290 shares in the last quarter. Finally, PYA Waltman Capital LLC increased its holdings in Danaher by 3.0% during the 3rd quarter. PYA Waltman Capital LLC now owns 33,368 shares of the conglomerate’s stock worth $9,277,000 after purchasing an additional 970 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Analysts Set New Price Targets

DHR has been the subject of a number of recent research reports. TD Cowen increased their price objective on shares of Danaher from $310.00 to $315.00 and gave the stock a “buy” rating in a research note on Wednesday, October 23rd. Barclays reduced their price objective on shares of Danaher from $285.00 to $275.00 and set an “equal weight” rating for the company in a research note on Wednesday, October 23rd. Raymond James reduced their price objective on shares of Danaher from $310.00 to $300.00 and set an “outperform” rating for the company in a research note on Wednesday, October 23rd. Royal Bank of Canada reduced their price objective on shares of Danaher from $333.00 to $311.00 and set an “outperform” rating for the company in a research note on Wednesday, October 23rd. Finally, KeyCorp raised their target price on shares of Danaher from $290.00 to $310.00 and gave the company an “overweight” rating in a research note on Wednesday, October 23rd. Six research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. According to data from MarketBeat.com, Danaher has a consensus rating of “Moderate Buy” and a consensus target price of $287.16.

Danaher Stock Performance

Shares of Danaher stock opened at $234.45 on Wednesday. Danaher Co. has a fifty-two week low of $217.96 and a fifty-two week high of $281.70. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01. The firm has a market capitalization of $169.34 billion, a P/E ratio of 44.74, a P/E/G ratio of 4.23 and a beta of 0.83. The company’s 50 day moving average price is $249.91 and its two-hundred day moving average price is $258.14.

Danaher (NYSE:DHR) last issued its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, beating analysts’ consensus estimates of $1.57 by $0.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The firm had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.59 billion. During the same quarter last year, the business posted $2.02 earnings per share. The company’s quarterly revenue was up 3.1% on a year-over-year basis. On average, equities analysts forecast that Danaher Co. will post 7.5 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Friday, December 27th will be issued a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.46%. Danaher’s dividend payout ratio (DPR) is presently 20.61%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.